News
Regeneron Pharmaceuticals recently reported earnings for Q1 2025 with a revenue drop to $3,029 million compared to the prior year, though net income increased, reflecting robust profitability with ...
Now in its landmark 75th year, Regeneron ISEF remains the premier global stage for the next generation of scientists and engineers. This milestone year celebrates decades of scientific discovery ...
How Does Regeneron Pharmaceuticals P/E Compare to Other Companies? The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's ...
Zoho's Sridhar Vembu cautioned software engineers about the potential for job losses due to advancements in AI and large language models. He emphasized that high compensation in the software ...
Fintel reports that on May 14, 2025, Citigroup upgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Neutral to Buy. As of May 6, 2025, the average one-year price target for ...
Needham native Latika Sridhar, a former engineer, has her first solo art exhibition, "Strange Mirror," opening May 9 at Established Gallery in Brooklyn. The exhibition features artwork Sridhar has ...
In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other cheap ESG stocks. These days, it seems like everyone wants to wear the ...
Throughout the last three months, 16 analysts have evaluated Regeneron Pharmaceuticals (NASDAQ:REGN), offering a diverse set of opinions from bullish to bearish. The following table summarizes ...
WASHINGTON, DC – Achyuta Rajaram, 17, of Exeter, NH, has been named the winner of won the top award in the Regeneron Science Talent Sea Achyuta Rajaram 2024, America’s oldest and most ...
Yancopoulos Innovator Award at the 75th Regeneron International Science and Engineering Fair (Regeneron ISEF), the world’s largest pre-college science and engineering competition. The award is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results